hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]

RxCUI: 1047795
RxNorm name: hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]
Display name: UTIRA (Oral Pill)
Full name: hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]
Term type: SBD
Status: Active
Strength: 0.12-81.6-10.8-36.2-40.8 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-08-03 17:30:06

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 012011
Active start: 012011
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
hyoscyamine sulfate	0.12 MG / 1 EACH	hyoscyamine	hyoscyamine sulfate
sodium phosphate, monobasic	40.8 MG / 1 EACH	sodium phosphate, monobasic	sodium phosphate, monobasic
phenyl salicylate	36.2 MG / 1 EACH	phenyl salicylate	phenyl salicylate
methenamine	81.6 MG / 1 EACH	methenamine	methenamine
methylene blue	10.8 MG / 1 EACH	methylene blue	methylene blue

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
hyoscyamine	153970
sodium phosphate, monobasic	235496
phenyl salicylate	36122
methenamine	6832
methylene blue	6878

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
PRESCRIBABLE	Y	ATTRIBUTES
RXNAV_STR	Utira-C (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet	NAMES
RxNorm Name	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]	NAMES
RxNorm Synonym	Utira-C (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet	NAMES
TTY	SBD	ATTRIBUTES
RxCUI	1047795	CODES
MMSL_CODE	BD29752	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00178051301	rxnav_ndcs	yes
10267276000	rxnav_historical_indirect
10267276001	rxnav_historical_indirect
51129446601	rxnav_historical
51129446602	rxnav_historical
63717051301	rxnav_historical
63717051399	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
a39b46a2-f7e1-444f-b992-6f81b5e306ef	Utira ® -C Tablet	Mission Pharmacal Company	20231122
c0f32207-0b2c-418b-a269-aa0a25097f37		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	V03AB	Antidotes	ATC1-4		methylene blue
ATC	A03BA	Belladonna alkaloids, tertiary amines	ATC1-4		hyoscyamine
ATC	J01XX	Other antibacterials	ATC1-4		methenamine
ATC	G04BX	Other urologicals	ATC1-4		phenyl salicylate
ATC	V04CG	Tests for gastric secretion	ATC1-4		methylene blue
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine sulfate
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine
MEDRT	D008709	Methenamine	CHEM	has_ingredient	methenamine
MEDRT	D008751	Methylene Blue	CHEM	has_ingredient	methylene blue
MEDRT	D010710	Phosphates	CHEM	has_ingredient	sodium phosphate, monobasic
MEDRT	D012459	Salicylates	CHEM	has_ingredient	phenyl salicylate
MEDRT	D013449	Sulfonamides	CHEM	ci_chemclass	methenamine
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine
MEDRT	D000471	Alkalosis	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D001437	Bacteriuria	DISEASE	may_treat	methenamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D003248	Constipation	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D003490	Cyanosis	DISEASE	may_treat	methylene blue
MEDRT	D003490	Cyanosis	DISEASE	may_prevent	methylene blue
MEDRT	D003556	Cystitis	DISEASE	may_treat	methenamine
MEDRT	D003681	Dehydration	DISEASE	ci_with	methenamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	methylene blue
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenyl salicylate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D004487	Edema	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D004927	Escherichia coli Infections	DISEASE	may_treat	methenamine
MEDRT	D005334	Fever	DISEASE	may_treat	phenyl salicylate
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine sulfate
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D048550	Hepatic Insufficiency	DISEASE	ci_with	methenamine
MEDRT	D006561	Herpes Simplex	DISEASE	may_treat	methylene blue
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D006955	Hypernatremia	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	methenamine
MEDRT	D006996	Hypocalcemia	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D017674	Hypophosphatemia	DISEASE	may_prevent	sodium phosphate, monobasic
MEDRT	D017674	Hypophosphatemia	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D007674	Kidney Diseases	DISEASE	ci_with	methenamine
MEDRT	D020347	Lithiasis	DISEASE	may_treat	methylene blue
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine
MEDRT	D008708	Methemoglobinemia	DISEASE	may_treat	methylene blue
MEDRT	D008708	Methemoglobinemia	DISEASE	induces	methylene blue
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D010146	Pain	DISEASE	may_prevent	phenyl salicylate
MEDRT	D010146	Pain	DISEASE	may_treat	phenyl salicylate
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine
MEDRT	D011041	Poisoning	DISEASE	may_treat	methylene blue
MEDRT	D011247	Pregnancy	DISEASE	ci_with	methylene blue
MEDRT	D011654	Pulmonary Edema	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D051437	Renal Insufficiency	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D051437	Renal Insufficiency	DISEASE	ci_with	methylene blue
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D013203	Staphylococcal Infections	DISEASE	may_treat	methenamine
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine
MEDRT	D014552	Urinary Tract Infections	DISEASE	may_prevent	methenamine
MEDRT	D014552	Urinary Tract Infections	DISEASE	may_treat	methylene blue
MEDRT	D020924	Urological Manifestations	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine sulfate
MEDRT	N0000000236	Alkylating Activity	MOA	has_moa	methylene blue
MEDRT	N0000175355	Binding Activity	MOA	has_moa	methylene blue
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000160	Cyclooxygenase Inhibitors	MOA	has_moa	phenyl salicylate
MEDRT	N0000000220	Electrolyte Activity	MOA	has_moa	sodium phosphate, monobasic
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000010288	Osmotic Activity	MOA	has_moa	sodium phosphate, monobasic
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	sodium phosphate, monobasic
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	methenamine
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	methylene blue
MEDRT	N0000008832	Decreased Platelet Aggregation	PE	has_pe	phenyl salicylate
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	phenyl salicylate
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000009006	Decreased Thromboxane Production	PE	has_pe	phenyl salicylate
MEDRT	N0000009371	Increased Large Intestinal Motility	PE	has_pe	sodium phosphate, monobasic
MEDRT	N0000009399	Increased Metabolic Rate	PE	has_pe	methylene blue
MEDRT	N0000009782	Oxygen Carrying Capacity Alteration	PE	has_pe	methylene blue
MEDRT	N0000009845	Small Intestine Fluid/Electrolyte Absorption Alteration	PE	has_pe	sodium phosphate, monobasic

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Utira	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	hyoscyamine	rxnav_allrelated
IN	IN	methenamine	rxnav_allrelated
IN	IN	methylene blue	rxnav_allrelated
IN	IN	phenyl salicylate	rxnav_allrelated
IN	IN	sodium phosphate, monobasic	rxnav_allrelated
MIN	MIN	hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic	rxnav_allrelated
PIN	PIN	hyoscyamine sulfate	rxnav_allrelated
SBD	SBD	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]	rxnav_allrelated
SBDC	SBDC	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Utira]	rxnav_allrelated
SBDF	SBDF	hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Utira]	rxnav_allrelated
SBDFP	SBDFP	hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Utira]	rxnav_allrelated
SBDG	SBDG	Utira Oral Product	rxnav_allrelated
SBDG	SBDG	Utira Pill	rxnav_allrelated
SCD	SCD	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	hyoscyamine sulfate 0.12 MG	rxnav_allrelated
SCDC	SCDC	methenamine 81.6 MG	rxnav_allrelated
SCDC	SCDC	methylene blue 10.8 MG	rxnav_allrelated
SCDC	SCDC	phenyl salicylate 36.2 MG	rxnav_allrelated
SCDC	SCDC	sodium phosphate, monobasic 40.8 MG	rxnav_allrelated
SCDF	SCDF	hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet	rxnav_allrelated
SCDFP	SCDFP	hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet	rxnav_allrelated
SCDG	SCDG	hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product	rxnav_allrelated
SCDG	SCDG	hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.12 MG / 81.6 MG / 10.8 MG / 36.2 MG / 40.8 MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	PRESCRIBABLE	Y
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	TTY	SBD
CODES	MMSL_CODE	BD29752
CODES	RxCUI	1047795
NAMES	Prescribable Synonym	Utira-C 0.12 MG / 81.6 MG / 36.2 MG / 40.8 MG / 10.8 MG Oral Tablet
NAMES	RXNAV_STR	Utira-C (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet
NAMES	RxNorm Name	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]
NAMES	RxNorm Synonym	Utira-C (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet

hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Utira]

RxNorm Status History#

Ingredients And Strength#

Dose Form Concepts#

Derived Ingredient Concepts#

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

UNII Substances#

DailyMed Labels#

Drug Classes#

Related Concepts#

Properties#